ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
11 announcements with these filters
Zenotech Laboratories Limited concluded its 37th Annual General Meeting. Shareholders approved the adoption of financial statements and re-appointment of Mr. Jignesh Anantray Goradia as Director.
Zenotech Laboratories Limited will hold its 37th Annual General Meeting on September 25, 2026, via video conferencing. The cut-off date for voting is September 18, 2026.
Zenotech Laboratories Ltd reported revenue from operations of ₹9.6 Cr (+11.6% YoY) and a net loss of ₹0.5 Cr for Q1 FY27.
Zenotech Laboratories will hold a board meeting on July 28, 2026. The board will consider unaudited standalone financial results for the June 2026 quarter.
Zenotech Laboratories submitted its Annual Secretarial Compliance Report for financial year 2025-26. The report highlights governance adherence and specific non-compliance regarding subsidiary financial disclosures.
Zenotech Laboratories Ltd reported revenue from operations of ₹8.9 Cr (-19.8% YoY) and a net loss of ₹3.2 Cr for Q4 FY26.
Zenotech Laboratories Ltd approved audited standalone financial results for the quarter and year ended March 31, 2026. The Board met on April 29, 2026, to review performance and the auditor's report. These results were prepared in accordance with Ind AS and Regulation 33 of SEBI Listing Regulations.
Zenotech Laboratories Limited confirmed it is not classified as a Large Corporate (LC) per SEBI's debt-raising framework. The company reported zero outstanding borrowings as of March 31, 2026. Consequently, mandatory initial disclosure requirements for large corporates do not apply.
Zenotech Laboratories Ltd reported net profit of ₹1.9 Cr (+11.8% YoY) for Q3 FY26.
Zenotech Laboratories Limited clarified to BSE that recent stock price movements are market-driven. The company confirmed compliance with Regulation 30 of SEBI (LODR) Regulations, 2015, stating no material information or impending announcements have been withheld.
Zenotech Laboratories Limited submitted its quarterly compliance certificate under Regulation 74(5) of SEBI Regulations for the period ended March 31, 2026. The certificate, issued by KFin Technologies Limited, confirms that share certificates received for dematerialization were processed and mutilated within the stipulated 15-day timeframe.